Finance

Lists
Q4 2026 earnings • in 5 days
See details
MMS:NYSE
Maximus Inc
$64.71
+0.21%
(+0.14) 1D
$65.00
+0.45% (+0.29)
After hours
Closed: Nov 13, 4:00:03 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MMS...
Open
$64.77
High
$66.10
Low
$64.34
Mkt. cap
3.39B
Avg. vol.
633.15K
Volume
449.08K
Dividend
2.04%
Quarterly dividend
$0.33
Ex-dividend date
Nov 13, 2026
P/E ratio
9.57
52-wk high
$100.00
52-wk low
$51.04
EPS
$6.76
Beta
0.57
Shares outstanding
52.36M
No. of employees
37K
Open
$64.77
High
$66.10
Low
$64.34
Mkt. cap
3.39B
Avg. vol.
633.15K
Volume
449.08K
Dividend
2.04%
Quarterly dividend
$0.33
Ex-dividend date
Nov 13, 2026
P/E ratio
9.57
52-wk high
$100.00
52-wk low
$51.04
EPS
$6.76
Beta
0.57
Shares outstanding
52.36M
No. of employees
37K
News stories
From web sources and news partners
Profile
Maximus Inc. is an American government services company, with operations in countries including the United States, Canada, and the United Kingdom. Maximus provides administration and other services for Medicaid, Medicare, health care reform, welfare-to-work, and student loan servicing, among other government programs. The company is based in Tysons, Virginia, has 39,600 employees and a reported annual revenue of $5.3 billion in fiscal year 2024. Wikipedia
About Maximus Inc
CEOBruce L. Caswell
Employees37.2K
Founded1975
Headquarters-
SectorIndustrials
IndustryService
Websitemaximus.com
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
BTIG
Buy
Maintained
$100.00
+54.5%
07/10/2026
Next call in 5 days
Thu, Nov 19, 4:00 PM
Fiscal period
Q4 2026
- / $1.85
Revenue / Est. (USD)
- / 1.30B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.32B
1.35B
1.31B
1.28B
Cost of goods sold
984.86M
1.03B
963.70M
930.17M
Cost of revenue
984.86M
1.03B
963.70M
930.17M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
227.03M
152.16M
173.48M
167.19M
Operating expense
250.03M
172.46M
193.78M
187.38M
Total operating expenses
1.23B
1.20B
1.16B
1.12B
Operating income
83.52M
146.21M
148.49M
161.43M
Other non operating income
37.00K
959.00K
2.94M
608.00K
EBT including unusual items
100.47M
126.27M
126.53M
138.16M
EBT excluding unusual items
61.12M
126.27M
126.53M
138.16M
Income tax expense
25.18M
32.32M
28.47M
34.56M
Effective tax rate
25.06%
25.60%
22.50%
25.02%
Other operating expenses
-
-
-
-
Net income
75.29M
93.94M
98.06M
103.59M
Net profit margin
5.71%
6.98%
7.51%
8.10%
Earnings per share
1.62
1.85
2.07
2.22
Interest and investment income
-
-
-
-
Interest expense
-22.43M
-20.82M
-22.11M
-23.88M
Net interest expenses
-22.43M
-20.82M
-22.11M
-23.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
98.49M
179.40M
181.11M
193.49M
Gain or loss from assets sale
206.00K
-8.98M
-
-1.16M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps